Table 3.

Predicted mean PPPM OAB‐specific US$ costs, by age, sex, and target therapy

				By target therapy
		All target therapies		Combi mira/AM		onabotulinumtoxinA		SNS		PTNS
		(n = 1662)		(n = 427)		(n = 456)		(n = 535)		(n = 245)
		Female	Male	Female	Male	Female	Male	Female	Male	Female	Male
From index to end of follow‐up		(n = 1385)	(n = 277)	(n = 312)	(n = 115)	(n = 400)	(n = 56)	(n = 477)	(n = 58)	(n = 197)	(n = 48)
Age	18‐65	698	551	415	385	364	293	1202	1121	258	255
	65+	614	487	382	354	362	298	1340	1215	310	333

Abbreviations: AM, antimuscarinic; mira, mirabegron; OAB, overactive bladder; PPPM, per‐member‐per‐month; PTNS, percutaneous tibial nerve stimulation; SD, standard deviation; SNS, sacral nerve stimulation.